nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Haematochezia—Epirubicin—bone cancer	0.0292	0.0292	CcSEcCtD
Roflumilast—Infection—Carboplatin—bone cancer	0.0276	0.0276	CcSEcCtD
Roflumilast—Haematochezia—Doxorubicin—bone cancer	0.027	0.027	CcSEcCtD
Roflumilast—Renal failure acute—Cisplatin—bone cancer	0.018	0.018	CcSEcCtD
Roflumilast—Hepatobiliary disease—Cisplatin—bone cancer	0.0121	0.0121	CcSEcCtD
Roflumilast—Connective tissue disorder—Cisplatin—bone cancer	0.0113	0.0113	CcSEcCtD
Roflumilast—Gynaecomastia—Methotrexate—bone cancer	0.0112	0.0112	CcSEcCtD
Roflumilast—Cardiac disorder—Cisplatin—bone cancer	0.0107	0.0107	CcSEcCtD
Roflumilast—Immune system disorder—Cisplatin—bone cancer	0.0104	0.0104	CcSEcCtD
Roflumilast—Mediastinal disorder—Cisplatin—bone cancer	0.0103	0.0103	CcSEcCtD
Roflumilast—Malnutrition—Cisplatin—bone cancer	0.00999	0.00999	CcSEcCtD
Roflumilast—Renal failure acute—Methotrexate—bone cancer	0.00986	0.00986	CcSEcCtD
Roflumilast—Muscle spasms—Cisplatin—bone cancer	0.00961	0.00961	CcSEcCtD
Roflumilast—Tremor—Cisplatin—bone cancer	0.00936	0.00936	CcSEcCtD
Roflumilast—Ill-defined disorder—Cisplatin—bone cancer	0.00927	0.00927	CcSEcCtD
Roflumilast—Renal failure acute—Epirubicin—bone cancer	0.00923	0.00923	CcSEcCtD
Roflumilast—Malaise—Cisplatin—bone cancer	0.00901	0.00901	CcSEcCtD
Roflumilast—Renal failure acute—Doxorubicin—bone cancer	0.00854	0.00854	CcSEcCtD
Roflumilast—Myalgia—Cisplatin—bone cancer	0.00851	0.00851	CcSEcCtD
Roflumilast—Anxiety—Cisplatin—bone cancer	0.00848	0.00848	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00845	0.00845	CcSEcCtD
Roflumilast—Discomfort—Cisplatin—bone cancer	0.00841	0.00841	CcSEcCtD
Roflumilast—Infection—Cisplatin—bone cancer	0.0081	0.0081	CcSEcCtD
Roflumilast—Nervous system disorder—Cisplatin—bone cancer	0.008	0.008	CcSEcCtD
Roflumilast—Skin disorder—Cisplatin—bone cancer	0.00792	0.00792	CcSEcCtD
Roflumilast—Gastritis—Epirubicin—bone cancer	0.00754	0.00754	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00743	0.00743	CcSEcCtD
Roflumilast—Influenza—Epirubicin—bone cancer	0.00737	0.00737	CcSEcCtD
Roflumilast—Decreased appetite—Cisplatin—bone cancer	0.00709	0.00709	CcSEcCtD
Roflumilast—Pneumonia—Methotrexate—bone cancer	0.00706	0.00706	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Cisplatin—bone cancer	0.00704	0.00704	CcSEcCtD
Roflumilast—Infestation—Methotrexate—bone cancer	0.00702	0.00702	CcSEcCtD
Roflumilast—Infestation NOS—Methotrexate—bone cancer	0.00702	0.00702	CcSEcCtD
Roflumilast—Depression—Methotrexate—bone cancer	0.007	0.007	CcSEcCtD
Roflumilast—Gastritis—Doxorubicin—bone cancer	0.00698	0.00698	CcSEcCtD
Roflumilast—Influenza—Doxorubicin—bone cancer	0.00682	0.00682	CcSEcCtD
Roflumilast—Feeling abnormal—Cisplatin—bone cancer	0.00672	0.00672	CcSEcCtD
Roflumilast—Weight decreased—Epirubicin—bone cancer	0.00666	0.00666	CcSEcCtD
Roflumilast—Hepatobiliary disease—Methotrexate—bone cancer	0.00664	0.00664	CcSEcCtD
Roflumilast—Pneumonia—Epirubicin—bone cancer	0.00661	0.00661	CcSEcCtD
Roflumilast—Infestation NOS—Epirubicin—bone cancer	0.00657	0.00657	CcSEcCtD
Roflumilast—Infestation—Epirubicin—bone cancer	0.00657	0.00657	CcSEcCtD
Roflumilast—Urinary tract infection—Epirubicin—bone cancer	0.00638	0.00638	CcSEcCtD
Roflumilast—Hepatobiliary disease—Epirubicin—bone cancer	0.00621	0.00621	CcSEcCtD
Roflumilast—Weight decreased—Doxorubicin—bone cancer	0.00617	0.00617	CcSEcCtD
Roflumilast—Sinusitis—Epirubicin—bone cancer	0.00616	0.00616	CcSEcCtD
Roflumilast—Pneumonia—Doxorubicin—bone cancer	0.00611	0.00611	CcSEcCtD
Roflumilast—Infestation NOS—Doxorubicin—bone cancer	0.00608	0.00608	CcSEcCtD
Roflumilast—Infestation—Doxorubicin—bone cancer	0.00608	0.00608	CcSEcCtD
Roflumilast—Hypersensitivity—Cisplatin—bone cancer	0.00601	0.00601	CcSEcCtD
Roflumilast—Rhinitis—Epirubicin—bone cancer	0.00591	0.00591	CcSEcCtD
Roflumilast—Urinary tract infection—Doxorubicin—bone cancer	0.00591	0.00591	CcSEcCtD
Roflumilast—Asthenia—Cisplatin—bone cancer	0.00585	0.00585	CcSEcCtD
Roflumilast—Cardiac disorder—Methotrexate—bone cancer	0.00585	0.00585	CcSEcCtD
Roflumilast—Connective tissue disorder—Epirubicin—bone cancer	0.00579	0.00579	CcSEcCtD
Roflumilast—Hepatobiliary disease—Doxorubicin—bone cancer	0.00575	0.00575	CcSEcCtD
Roflumilast—Sinusitis—Doxorubicin—bone cancer	0.0057	0.0057	CcSEcCtD
Roflumilast—Immune system disorder—Methotrexate—bone cancer	0.00569	0.00569	CcSEcCtD
Roflumilast—Mediastinal disorder—Methotrexate—bone cancer	0.00568	0.00568	CcSEcCtD
Roflumilast—Diarrhoea—Cisplatin—bone cancer	0.00558	0.00558	CcSEcCtD
Roflumilast—Mental disorder—Methotrexate—bone cancer	0.00552	0.00552	CcSEcCtD
Roflumilast—Malnutrition—Methotrexate—bone cancer	0.00548	0.00548	CcSEcCtD
Roflumilast—Cardiac disorder—Epirubicin—bone cancer	0.00547	0.00547	CcSEcCtD
Roflumilast—Rhinitis—Doxorubicin—bone cancer	0.00547	0.00547	CcSEcCtD
Roflumilast—Dysgeusia—Methotrexate—bone cancer	0.00537	0.00537	CcSEcCtD
Roflumilast—Connective tissue disorder—Doxorubicin—bone cancer	0.00536	0.00536	CcSEcCtD
Roflumilast—Immune system disorder—Epirubicin—bone cancer	0.00533	0.00533	CcSEcCtD
Roflumilast—Mediastinal disorder—Epirubicin—bone cancer	0.00531	0.00531	CcSEcCtD
Roflumilast—Back pain—Methotrexate—bone cancer	0.00531	0.00531	CcSEcCtD
Roflumilast—Vomiting—Cisplatin—bone cancer	0.00519	0.00519	CcSEcCtD
Roflumilast—Mental disorder—Epirubicin—bone cancer	0.00517	0.00517	CcSEcCtD
Roflumilast—Rash—Cisplatin—bone cancer	0.00514	0.00514	CcSEcCtD
Roflumilast—Dermatitis—Cisplatin—bone cancer	0.00514	0.00514	CcSEcCtD
Roflumilast—Malnutrition—Epirubicin—bone cancer	0.00513	0.00513	CcSEcCtD
Roflumilast—Ill-defined disorder—Methotrexate—bone cancer	0.00509	0.00509	CcSEcCtD
Roflumilast—Cardiac disorder—Doxorubicin—bone cancer	0.00506	0.00506	CcSEcCtD
Roflumilast—Tension—Epirubicin—bone cancer	0.00504	0.00504	CcSEcCtD
Roflumilast—Dysgeusia—Epirubicin—bone cancer	0.00503	0.00503	CcSEcCtD
Roflumilast—Nervousness—Epirubicin—bone cancer	0.00499	0.00499	CcSEcCtD
Roflumilast—Back pain—Epirubicin—bone cancer	0.00496	0.00496	CcSEcCtD
Roflumilast—Malaise—Methotrexate—bone cancer	0.00495	0.00495	CcSEcCtD
Roflumilast—Muscle spasms—Epirubicin—bone cancer	0.00493	0.00493	CcSEcCtD
Roflumilast—Immune system disorder—Doxorubicin—bone cancer	0.00493	0.00493	CcSEcCtD
Roflumilast—Vertigo—Methotrexate—bone cancer	0.00493	0.00493	CcSEcCtD
Roflumilast—Mediastinal disorder—Doxorubicin—bone cancer	0.00492	0.00492	CcSEcCtD
Roflumilast—Nausea—Cisplatin—bone cancer	0.00485	0.00485	CcSEcCtD
Roflumilast—Mental disorder—Doxorubicin—bone cancer	0.00478	0.00478	CcSEcCtD
Roflumilast—Ill-defined disorder—Epirubicin—bone cancer	0.00476	0.00476	CcSEcCtD
Roflumilast—Malnutrition—Doxorubicin—bone cancer	0.00475	0.00475	CcSEcCtD
Roflumilast—Myalgia—Methotrexate—bone cancer	0.00467	0.00467	CcSEcCtD
Roflumilast—Tension—Doxorubicin—bone cancer	0.00466	0.00466	CcSEcCtD
Roflumilast—Dysgeusia—Doxorubicin—bone cancer	0.00465	0.00465	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00464	0.00464	CcSEcCtD
Roflumilast—Malaise—Epirubicin—bone cancer	0.00463	0.00463	CcSEcCtD
Roflumilast—Discomfort—Methotrexate—bone cancer	0.00461	0.00461	CcSEcCtD
Roflumilast—Nervousness—Doxorubicin—bone cancer	0.00461	0.00461	CcSEcCtD
Roflumilast—Vertigo—Epirubicin—bone cancer	0.00461	0.00461	CcSEcCtD
Roflumilast—Back pain—Doxorubicin—bone cancer	0.00459	0.00459	CcSEcCtD
Roflumilast—Muscle spasms—Doxorubicin—bone cancer	0.00457	0.00457	CcSEcCtD
Roflumilast—Palpitations—Epirubicin—bone cancer	0.00454	0.00454	CcSEcCtD
Roflumilast—Infection—Methotrexate—bone cancer	0.00445	0.00445	CcSEcCtD
Roflumilast—Ill-defined disorder—Doxorubicin—bone cancer	0.00441	0.00441	CcSEcCtD
Roflumilast—Nervous system disorder—Methotrexate—bone cancer	0.00439	0.00439	CcSEcCtD
Roflumilast—Myalgia—Epirubicin—bone cancer	0.00437	0.00437	CcSEcCtD
Roflumilast—Anxiety—Epirubicin—bone cancer	0.00435	0.00435	CcSEcCtD
Roflumilast—Skin disorder—Methotrexate—bone cancer	0.00435	0.00435	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00434	0.00434	CcSEcCtD
Roflumilast—Discomfort—Epirubicin—bone cancer	0.00432	0.00432	CcSEcCtD
Roflumilast—Malaise—Doxorubicin—bone cancer	0.00428	0.00428	CcSEcCtD
Roflumilast—Vertigo—Doxorubicin—bone cancer	0.00427	0.00427	CcSEcCtD
Roflumilast—Palpitations—Doxorubicin—bone cancer	0.0042	0.0042	CcSEcCtD
Roflumilast—Infection—Epirubicin—bone cancer	0.00416	0.00416	CcSEcCtD
Roflumilast—Nervous system disorder—Epirubicin—bone cancer	0.00411	0.00411	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00408	0.00408	CcSEcCtD
Roflumilast—Skin disorder—Epirubicin—bone cancer	0.00407	0.00407	CcSEcCtD
Roflumilast—Insomnia—Methotrexate—bone cancer	0.00405	0.00405	CcSEcCtD
Roflumilast—Myalgia—Doxorubicin—bone cancer	0.00404	0.00404	CcSEcCtD
Roflumilast—Anxiety—Doxorubicin—bone cancer	0.00403	0.00403	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00402	0.00402	CcSEcCtD
Roflumilast—Discomfort—Doxorubicin—bone cancer	0.00399	0.00399	CcSEcCtD
Roflumilast—Dyspepsia—Methotrexate—bone cancer	0.00394	0.00394	CcSEcCtD
Roflumilast—Decreased appetite—Methotrexate—bone cancer	0.00389	0.00389	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Methotrexate—bone cancer	0.00386	0.00386	CcSEcCtD
Roflumilast—Fatigue—Methotrexate—bone cancer	0.00386	0.00386	CcSEcCtD
Roflumilast—Infection—Doxorubicin—bone cancer	0.00385	0.00385	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00382	0.00382	CcSEcCtD
Roflumilast—Nervous system disorder—Doxorubicin—bone cancer	0.0038	0.0038	CcSEcCtD
Roflumilast—Insomnia—Epirubicin—bone cancer	0.00379	0.00379	CcSEcCtD
Roflumilast—Skin disorder—Doxorubicin—bone cancer	0.00376	0.00376	CcSEcCtD
Roflumilast—Feeling abnormal—Methotrexate—bone cancer	0.00369	0.00369	CcSEcCtD
Roflumilast—Dyspepsia—Epirubicin—bone cancer	0.00369	0.00369	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methotrexate—bone cancer	0.00366	0.00366	CcSEcCtD
Roflumilast—Decreased appetite—Epirubicin—bone cancer	0.00364	0.00364	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Epirubicin—bone cancer	0.00362	0.00362	CcSEcCtD
Roflumilast—Fatigue—Epirubicin—bone cancer	0.00361	0.00361	CcSEcCtD
Roflumilast—Constipation—Epirubicin—bone cancer	0.00358	0.00358	CcSEcCtD
Roflumilast—Urticaria—Methotrexate—bone cancer	0.00356	0.00356	CcSEcCtD
Roflumilast—Abdominal pain—Methotrexate—bone cancer	0.00354	0.00354	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00353	0.00353	CcSEcCtD
Roflumilast—Insomnia—Doxorubicin—bone cancer	0.00351	0.00351	CcSEcCtD
Roflumilast—Feeling abnormal—Epirubicin—bone cancer	0.00345	0.00345	CcSEcCtD
Roflumilast—Gastrointestinal pain—Epirubicin—bone cancer	0.00343	0.00343	CcSEcCtD
Roflumilast—Dyspepsia—Doxorubicin—bone cancer	0.00341	0.00341	CcSEcCtD
Roflumilast—Decreased appetite—Doxorubicin—bone cancer	0.00337	0.00337	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00335	0.00335	CcSEcCtD
Roflumilast—Fatigue—Doxorubicin—bone cancer	0.00334	0.00334	CcSEcCtD
Roflumilast—Urticaria—Epirubicin—bone cancer	0.00333	0.00333	CcSEcCtD
Roflumilast—Constipation—Doxorubicin—bone cancer	0.00331	0.00331	CcSEcCtD
Roflumilast—Abdominal pain—Epirubicin—bone cancer	0.00331	0.00331	CcSEcCtD
Roflumilast—Hypersensitivity—Methotrexate—bone cancer	0.0033	0.0033	CcSEcCtD
Roflumilast—Asthenia—Methotrexate—bone cancer	0.00321	0.00321	CcSEcCtD
Roflumilast—Feeling abnormal—Doxorubicin—bone cancer	0.00319	0.00319	CcSEcCtD
Roflumilast—Gastrointestinal pain—Doxorubicin—bone cancer	0.00317	0.00317	CcSEcCtD
Roflumilast—Hypersensitivity—Epirubicin—bone cancer	0.00309	0.00309	CcSEcCtD
Roflumilast—Urticaria—Doxorubicin—bone cancer	0.00308	0.00308	CcSEcCtD
Roflumilast—Abdominal pain—Doxorubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Roflumilast—Diarrhoea—Methotrexate—bone cancer	0.00306	0.00306	CcSEcCtD
Roflumilast—Asthenia—Epirubicin—bone cancer	0.00301	0.00301	CcSEcCtD
Roflumilast—Dizziness—Methotrexate—bone cancer	0.00296	0.00296	CcSEcCtD
Roflumilast—Diarrhoea—Epirubicin—bone cancer	0.00287	0.00287	CcSEcCtD
Roflumilast—Hypersensitivity—Doxorubicin—bone cancer	0.00286	0.00286	CcSEcCtD
Roflumilast—Vomiting—Methotrexate—bone cancer	0.00285	0.00285	CcSEcCtD
Roflumilast—Rash—Methotrexate—bone cancer	0.00282	0.00282	CcSEcCtD
Roflumilast—Dermatitis—Methotrexate—bone cancer	0.00282	0.00282	CcSEcCtD
Roflumilast—Headache—Methotrexate—bone cancer	0.0028	0.0028	CcSEcCtD
Roflumilast—Asthenia—Doxorubicin—bone cancer	0.00278	0.00278	CcSEcCtD
Roflumilast—Dizziness—Epirubicin—bone cancer	0.00277	0.00277	CcSEcCtD
Roflumilast—Vomiting—Epirubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Roflumilast—Nausea—Methotrexate—bone cancer	0.00266	0.00266	CcSEcCtD
Roflumilast—Diarrhoea—Doxorubicin—bone cancer	0.00265	0.00265	CcSEcCtD
Roflumilast—Rash—Epirubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Roflumilast—Dermatitis—Epirubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Roflumilast—Headache—Epirubicin—bone cancer	0.00262	0.00262	CcSEcCtD
Roflumilast—Dizziness—Doxorubicin—bone cancer	0.00256	0.00256	CcSEcCtD
Roflumilast—Nausea—Epirubicin—bone cancer	0.00249	0.00249	CcSEcCtD
Roflumilast—Vomiting—Doxorubicin—bone cancer	0.00246	0.00246	CcSEcCtD
Roflumilast—Rash—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Roflumilast—Dermatitis—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Roflumilast—Headache—Doxorubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Roflumilast—Nausea—Doxorubicin—bone cancer	0.0023	0.0023	CcSEcCtD
